Skip to content

REPROBIOL: what changed

BE 0886.862.189NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€71,400
2024 · €95,318-€23,918
Equity
€1.5m
2024 · €1.5m-€5,895
Cash
€650,344
2024 · €342,878+€307,467
Balance sheet total
€1.9m
2024 · €1.8m+€96,887

Largest movements

2024 to 2025
Assets
  • Cash +€307,467

    up €307,467 (+89.7%), from €342,878 to €650,344

    mainly Depreciation (+€99,012) and Trade debts (+€93,901)

  • Receivables within one year -€84,569

    down €84,569 (-55.1%), from €153,476 to €68,907

    of which Trade receivables: -€53,228

  • Tangible fixed assets -€70,818

    down €70,818 (-6.4%), from €1.1m to €1.0m

    of which Land and buildings: -€47,038

  • Stocks and contracts -€29,266

    down €29,266 (-22.4%), from €130,856 to €101,590

  • Current investments -€26,667

    down €26,667 (-31.8%), from €83,810 to €57,143

Equity and liabilities
  • Trade debts +€93,901

    up €93,901 (+247%), from €37,994 to €131,895

  • Other debts +€55,000

    up €55,000 (+275%), from €20,000 to €75,000

  • Debts after one year -€39,126

    down €39,126 (-20.2%), from €193,485 to €154,360

Income statement
  • Gross operating margin -€25,154

    down €25,154 (-5.0%), from €504,975 to €479,821

  • Depreciation +€14,164

    up €14,164 (+16.7%), from €84,848 to €99,012

  • Staff costs -€10,658

    down €10,658 (-3.7%), from €291,810 to €281,151

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €95,318
Gross operating margin -€25,154
Staff costs +€10,658
Depreciation -€14,164
Other operating charges +€426
Financial income -€226
Financial charges +€1,001
Taxes +€3,541
Result 2025 €71,400
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€421,991
Investment +€1,073
Financing -€115,598
Cash 2024 €342,878
Net result for the year +€71,400
Depreciation +€99,012
Stocks and contracts +€29,266
Receivables within one year +€84,569
Deferred charges and accrued income -€3,340
Trade debts +€93,901
Tax, wage and social debts -€7,817
Other debts +€55,000
Investment in fixed assets (net) -€25,594
Current investments +€26,667
Debts after one year -€39,126
Current portion of long-term debt +€823
Contributions, distributions and other -€77,295
Cash 2025 €650,344
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,833,669 €1,930,556 +€96,887 +5.3%
Fixed assets 21/28 €1,114,038 €1,040,620 -€73,418 -6.6%
Tangible fixed assets 22/27 €1,111,388 €1,040,570 -€70,818 -6.4%
Land and buildings 22 €702,586 €655,548 -€47,038 -6.7%
Plant, machinery and equipment 23 €407,425 €382,435 -€24,990 -6.1%
Furniture and vehicles 24 €971 €2,384 +€1,413 +146%
Other tangible fixed assets 26 €406 €203 -€203 -50.0%
Financial fixed assets 28 €2,650 €50 -€2,600 -98.1%
Current assets 29/58 €719,631 €889,936 +€170,305 +23.7%
Stocks and contracts in progress 3 €130,856 €101,590 -€29,266 -22.4%
Stocks 30/36 €130,856 €101,590 -€29,266 -22.4%
Amounts receivable within one year 40/41 €153,476 €68,907 -€84,569 -55.1%
Trade receivables 40 €70,768 €17,540 -€53,228 -75.2%
Other amounts receivable 41 €82,708 €51,367 -€31,341 -37.9%
Current investments 50/53 €83,810 €57,143 -€26,667 -31.8%
Cash at bank and in hand 54/58 €342,878 €650,344 +€307,467 +89.7%
Deferred charges and accrued income 490/1 €8,613 €11,952 +€3,340 +38.8%
Total equity and liabilities 10/49 €1,833,669 €1,930,556 +€96,887 +5.3%
Equity 10/15 €1,511,313 €1,505,418 -€5,895 -0.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €879,003 €879,003 = 0.0%
Non-distributable reserves 130/1 €57,143 €57,143 = 0.0%
Own shares acquired 1312 €57,143 €57,143 = 0.0%
Distributable reserves 133 €821,860 €821,860 = 0.0%
Profit (loss) carried forward 14 €567,187 €563,587 -€3,600 -0.6%
Investment grants 15 €46,524 €44,228 -€2,295 -4.9%
Amounts payable 17/49 €322,356 €425,138 +€102,782 +31.9%
Amounts payable after more than one year 17 €193,485 €154,360 -€39,126 -20.2%
Financial debts 170/4 €193,485 €154,360 -€39,126 -20.2%
Amounts payable within one year 42/48 €128,870 €270,778 +€141,908 +110%
Current portion of amounts payable after more than one year 42 €38,302 €39,126 +€823 +2.1%
Trade debts 44 €37,994 €131,895 +€93,901 +247%
Suppliers 440/4 €37,994 €131,895 +€93,901 +247%
Advances received on contracts in progress 46 €865 €865 = 0.0%
Taxes, remuneration and social security 45 €31,709 €23,893 -€7,817 -24.7%
Taxes 450/3 - €5,132 +€5,132
Remuneration and social security 454/9 €31,709 €18,760 -€12,949 -40.8%
Other amounts payable 47/48 €20,000 €75,000 +€55,000 +275%
Remuneration, social security and pensions 62 €291,810 €281,151 -€10,658 -3.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €84,848 €99,012 +€14,164 +16.7%
Other operating charges 640/8 €1,524 €1,098 -€426 -27.9%
Gross operating margin 9900 €504,975 €479,821 -€25,154 -5.0%
Operating profit (loss) 9901 €126,794 €98,559 -€28,234 -22.3%
Financial income 75/76B €5,227 €5,001 -€226 -4.3%
Recurring financial income 75 €5,227 €5,001 -€226 -4.3%
Financial charges 65/66B €8,336 €7,336 -€1,001 -12.0%
Recurring financial charges 65 €8,336 €7,336 -€1,001 -12.0%
Profit (loss) for the period before taxes 9903 €123,684 €96,225 -€27,459 -22.2%
Income taxes 67/77 €28,366 €24,825 -€3,541 -12.5%
Profit (loss) for the period 9904 €95,318 €71,400 -€23,918 -25.1%
Profit (loss) for the period to be appropriated 9905 €95,318 €71,400 -€23,918 -25.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€1.2m to €1.4m

Midpoint €1.3m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €1.5m
Capitalised earnings €945,607 to €1.3m
Indication €1.2m to €1.4m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,505,418
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.5m

Capitalised earnings

net result for the year (9904)
2025
€71,400
2024
€95,318
2023
€230,435
2022
€216,835
2021
€102,250
Average result
€132,385
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€945,607 / €1.1m / €1.3m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.